UHT UNIVERSAL HEALTH REALTY INCOME TRUST
Real Estate Investment Trusts · NYSE · SEC CIK 798783 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $25.35M | $24.99M | $24.53M | $24.47M | $25.30M | $24.87M | $24.55M | $24.64M |
| Operating income | $8.96M | $9.20M | $8.96M | $8.49M | $8.39M | $8.84M | $9.03M | $9.26M |
| Net income | $4.93M | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | $4.78M | $4.66M |
| EBITDA | $16.02M | $16.23M | $15.91M | $15.61M | $16.30M | $15.84M | $15.88M | $16.06M |
| EPS (basic) | 0.36 | 0.43 | 0.36 | — | 0.29 | 0.33 | 0.35 | — |
| EPS (diluted) | 0.35 | 0.43 | 0.36 | — | 0.29 | 0.32 | 0.34 | — |
| Dividends declared per share | 750.00 | 750.00 | 0.74 | 0.75 | 740.00 | 740.00 | 0.73 | 0.73 |
| Weighted avg. shares (diluted) | 13.90M | 13.88M | 13.88M | — | 13.87M | 13.86M | 13.85M | — |
| Banking | ||||||||
| Net interest income | -$4.53M | -$4.45M | -$4.45M | -$4.65M | -$4.82M | -$4.72M | -$4.67M | -$4.92M |
| Balance sheet | ||||||||
| Cash & equivalents | $6.47M | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | $6.97M | $7.10M |
| Intangibles | $4.50M | $4.87M | $5.25M | $5.64M | $6.04M | $6.46M | $6.89M | $7.33M |
| Total assets | $573.01M | $567.12M | $563.76M | $564.91M | $568.04M | $573.02M | $573.48M | $580.86M |
| Long-term debt | — | — | — | $374.77M | — | — | — | $368.41M |
| Total debt | — | — | — | $374.77M | — | — | — | $368.41M |
| Total liabilities | $433.51M | $423.21M | $415.96M | $412.52M | $409.46M | $407.86M | $401.32M | $401.32M |
| Shareholders' equity | $139.50M | $143.91M | $147.80M | $152.38M | $158.57M | $165.15M | $172.17M | $179.54M |
| Net debt | — | — | — | $368.09M | — | — | — | $361.31M |
| Shares outstanding | 13.90M | 13.90M | 13.88M | 13.87M | 13.87M | 13.87M | 13.85M | 13.85M |
| Cash flow statement | ||||||||
| Operating cash flow | $9.12M | $12.40M | $11.95M | $13.60M | $10.20M | $13.69M | $11.61M | $13.15M |
| Investing cash flow | -$11.18M | -$7.84M | -$4.46M | -$2.52M | -$1.75M | -$8.79M | -$1.90M | -$2.71M |
| Financing cash flow | $1.71M | -$4.81M | -$7.12M | -$11.30M | -$8.09M | -$5.32M | -$9.84M | -$9.72M |
| Depreciation & amortization | $7.05M | $7.03M | $6.95M | $7.12M | $7.90M | $6.99M | $6.84M | $6.80M |
| Stock-based compensation | $224,000 | $203,000 | $190,000 | $274,000 | $236,000 | $213,000 | $213,000 | $218,000 |
| Dividends paid | $10.40M | $10.50M | $10.30M | $10.31M | $10.30M | $10.30M | $10.15M | $10.15M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.